The neuropathological diagnosis of Alzheimer disease.

The unequivocal diagnosis of Alzheimer disease (AD) rests on histopathological evidence at brain autopsy or biopsy. Although the histological features of AD are well known, defining criteria for the morphological diagnosis of AD is difficult due to the phenotypical heterogeneity of the disease, absence of specific markers, and overlap of AD pathology with that observed in non-demented elderly individuals. This gray zone between normal to pathological aging and full-fledged AD represents an important diagnostic problem and should be overcome by better standardized criteria that will allow to minimize interrater and interlaboratory variability in the diagnosis of AD. Current criteria for the neuropathological diagnosis of AD are based on age-related (semi)quantitative assessment of "senile" plaques (NIA criteria), neuritic plaques (CERAD), plaques and neurofibrillary tangles in neocortex and hippocampus (Tierney et al., 1988), and staging of hierarchic spreading of neuritic AD changes in particular, neurofibrillary tangles (Braak and Braak, 1991). All these algorithms have some weaknesses and do not recognize the various subtypes of AD. Multivariant analysis of an autopsy series of elderly subjects revealed significant correlations between psychostatus assessed by the Mini-Mental State and both the CERAD criteria and Braak staging. Although the role of plaques and tangles in the pathogenesis of AD and their relationship to both neuronal loss and dementia remain to be elucidated, clinicopathological studies have shown that both lesions, if present in sufficient numbers, particularly in the neocortex, are considered the best correlates for AD related dementia. Recent consensus recommendations of the NIA- and Reagan Institute Working Group for the morphological diagnosis of AD consider AD as a heterogenous clinicopathological entity. After exclusion of other causes of dementia, the likelihood that AD accounts for dementia is considered high, intermediate or low according to the frequency of neuritic AD lesions with regard to both the CERAD criteria and Braak staging. The evaluation of small autopsy series according to these criteria demonstrated their easy and rapid application in AD and non-demented subjects, with much less reliability for other dementing disorders.

[1]  C. Kawas,et al.  Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging , 1996, Neurobiology of Aging.

[2]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[3]  J. Miller,et al.  Neuropathological indexes of Alzheimer's disease in demented and nondemented persons aged 80 years and older. , 1993, Archives of neurology.

[4]  R. Mohs,et al.  Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.

[5]  D. Salmon,et al.  Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment , 1991, Annals of neurology.

[6]  H. Braak,et al.  Staging of Alzheimer-type pathology: an interrater-intrarater study. , 1997, Dementia and geriatric cognitive disorders.

[7]  R. Crowther,et al.  Comparison of the neurofibrillary pathology in Alzheimer’s disease and familial presenile dementia with tangles , 1996, Acta Neuropathologica.

[8]  A. Smith,et al.  The Effects of Additional Pathology on the Cognitive Deficit in Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[9]  D. Bennett,et al.  Pathological changes in frontal cortex from biopsy to autopsy in Alzheimer's disease , 1993, Neurobiology of Aging.

[10]  H. Chui,et al.  Differentiating Alzheimer Disease and Vascular Dementia: Reframing the Question , 1997 .

[11]  K. Jellinger,et al.  Synaptic pathology in alzheimer's disease: Immunological data for markers of synaptic and large dense-core vesicles , 1992, Neuroscience.

[12]  Jellinger Ka.  Structural basis of dementia in neurodegenerative disorders , 1996 .

[13]  M. Gearing,et al.  Neuropathologic assessment of Alzheimer's disease , 1997, Neurology.

[14]  B. Hyman,et al.  CEREBRAL INFARCTION CONTRIBUTES TO THE HETEROGENEITY OF ALZHEIMERʼS DISEASE (AD) , 1997 .

[15]  I. Mackenzie,et al.  Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques , 1996, Neurology.

[16]  A. Smith,et al.  Hippocampal pathology reflects memory deficit and brain imaging measurements in Alzheimer's disease: clinicopathologic correlations using three sets of pathologic diagnostic criteria. , 1996, Dementia.

[17]  S. Younkin,et al.  Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice , 1996, Science.

[18]  C. Kawas,et al.  In Situ Labeling of Dying Cortical Neurons in Normal Aging and in Alzheimer’s Disease: Correlations with Senile Plaques and Disease Progression , 1996, Journal of neuropathology and experimental neurology.

[19]  D. Perl,et al.  CLINICOPATHOLOGIC CORRELATIONS OF THE ALZHEIMERʼS DISEASE STAGING SYSTEM INTRODUCED BY BRAAK AND BRAAK , 1997 .

[20]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[21]  R. Defendini,et al.  The neuropathology of chromosome 17‐linked dementia , 1996, Annals of neurology.

[22]  J. Ashford,et al.  Comparison of Neuropathologic Criteria for the Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[23]  Peter Davies,et al.  Identification of normal and pathological aging in prospectively studied nondemented elderly humans , 1992, Neurobiology of Aging.

[24]  W. Markesbery,et al.  Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. , 1997, JAMA.

[25]  M. Folstein,et al.  Accuracy of Clinical Diagnosis of Alzheimer Disease and Clinical Features of Patients with Non-Alzheimer Disease Neuropathology , 1996, Alzheimer disease and associated disorders.

[26]  Z. Khachaturian.  Diagnosis of Alzheimer's disease. , 1985, Archives of neurology.

[27]  J. Morris,et al.  Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease , 1996, The Journal of Neuroscience.

[28]  K. Kosik,et al.  Neuritic pathology and dementia in alzheimer's disease , 1991, Annals of neurology.

[29]  John X. Morris,et al.  The diagnosis of Alzheimer's disease. , 1999, Journal of Alzheimer's disease : JAD.

[30]  D. Dickson,et al.  The Pathogenesis of Senile Plaques , 1997, Journal of neuropathology and experimental neurology.

[31]  K. Jellinger,et al.  Proposals for Re-evaluation of Current Autopsy Criteria for the Diagnosis of Alzheimer’s Disease , 1997, Neurobiology of Aging.

[32]  N L Foster,et al.  Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference , 1997, Annals of neurology.

[33]  Alistair Burns,et al.  Diagnosis of Alzheimer's Disease , 1997, International Psychogeriatrics.

[34]  M. Albert,et al.  Reliability and validity of NINCDS-ADRDA criteria for Alzheimer's disease. The National Institute of Mental Health Genetics Initiative. , 1994, Archives of neurology.

[35]  P. Lantos,et al.  Familial dementia with swollen achromatic neurons and corticobasal inclusion bodies: a clinical and pathological study , 1996, Journal of the Neurological Sciences.

[36]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part X. Neuropathology Confirmation of the Clinical Diagnosis of Alzheimer's Disease , 1995, Neurology.

[37]  J. Growdon,et al.  Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease. , 1999, Journal of neuropathology and experimental neurology.

[38]  J. Price,et al.  The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease , 1991, Neurobiology of Aging.

[39]  E. Masliah,et al.  Plaque‐Only Alzheimer Disease is Usually the Lewy Body Variant, and Vice Versa , 1993, Journal of neuropathology and experimental neurology.

[40]  H. Wiśniewski,et al.  Pathology of Alzheimer's disease. , 1991, The Psychiatric clinics of North America.

[41]  K. Jellinger,et al.  Neuropathologic diagnosis of Alzheimer disease: consensus between practicing neuropathologists? , 1997, Alzheimer disease and associated disorders.

[42]  A. Smith,et al.  Cell cycle markers in the hippocampus in Alzheimer’s disease , 1997, Acta Neuropathologica.

[43]  N Butters,et al.  Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia. , 1994, Archives of neurology.

[44]  W. Honer,et al.  Correlations of synaptic and pathological markers with cognition of the elderly , 1995, Neurobiology of Aging.

[45]  D. Munoz,et al.  Qualitative and Quantitative Differences in Senile Plaque Dystrophie Neurites of Alzheimer's Disease and Normal Aged Brain , 1995, Journal of neuropathology and experimental neurology.

[46]  S. Mirra,et al.  Making the diagnosis of Alzheimer's disease. A primer for practicing pathologists. , 1993, Archives of pathology & laboratory medicine.

[47]  J. Price,et al.  Cerebral amyloid deposition and diffuse plaques in ``normal'' aging , 1996, Neurology.

[48]  I Litvan,et al.  Validity and Reliability of the Preliminary NINDS Neuropathologic Criteria for Progressive Supranuclear Palsy and Related Disorders , 1996, Journal of neuropathology and experimental neurology.

[49]  J. Ulrich.  Abundant neurofibrillary tangles without senile plaques in a subset of patients with senile dementia , 1992 .

[50]  Brian J Cummings,et al.  β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease , 1996, Neurobiology of Aging.

[51]  B. Hyman.  Anatomy of Pathological Alterations in Alzheimer’s Disease , 1997 .

[52]  D. Price,et al.  Synapse loss in the temporal lobe in Alzheimer's disease , 1993, Annals of neurology.

[53]  G. K. Wilcock,et al.  Plaques, tangles and dementia A quantitative study , 1982, Journal of the Neurological Sciences.

[54]  H. Akiyama,et al.  A subset of senile dementia with high incidence of the apolipoprotein E ϵ2 allele , 1997 .

[55]  M. Gearing,et al.  ALZHEIMERʼS DISEASE WITH CONCOMITANT PARKINSONʼS DISEASE CHANGES: TWO SUBGROUPS DEFINED BY NEUROFIBRILLARY PATHOLOGY , 1997 .

[56]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[57]  L A Hansen,et al.  Clinical-neuropathological correlations in Alzheimer's disease and related dementias. , 1994, Archives of neurology.

[58]  J. Trojanowski,et al.  Relationship between plaques, tangles, and dystrophic processes in Alzheimer's disease , 1995, Neurobiology of Aging.

[59]  J. Growdon,et al.  EVALUATION OF NIA-REAGAN INSTITUTE CRITERIA FOR THE NEUROPATHOLOGICAL DIAGNOSIS OF ALZHEIMER DISEASE , 1997 .

[60]  β‐Amyloidosis in Normal Aging and Transmitter Signaling in Human Temporal Lobe a , 1996 .

[61]  B. Corain.  Alzheimer's disease : advances in clinical and basic research , 1993 .

[62]  W. Snow,et al.  The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease , 1988, Neurology.

[63]  R. Katzman.,et al.  Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques , 1988, Annals of neurology.

[64]  K. Jellinger,et al.  Interrater reliability in the neuropathologic diagnosis of Alzheimer's disease , 1992, Neurology.

[65]  Bradley T. Hyman,et al.  Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease , 1992, Neurology.

[66]  K. Davis,et al.  Neurochemical Correlates of Dementia Severity in Alzheimer's Disease: Relative Importance of the Cholinergic Deficits , 1995, Journal of neurochemistry.

[67]  K. Iqbal,et al.  Research advances in Alzheimer's disease and related disorders , 1995 .

[68]  L. R. Hill,et al.  Hippocampal connectivity and Alzheimer's dementia , 1994, Neurology.

[69]  S. M. Sumi,et al.  Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala , 1992, Neurology.

[70]  K. Jellinger,et al.  Low prevalence of apolipoprotein E ε4 allele in the neurofibrillary tangle predominant form of senile dementia , 1997, Acta Neuropathologica.

[71]  Panteleimon Giannakopoulos,et al.  Distinct Patterns of Neuronal Loss and Alzheimer's Disease Lesion Distribution in Elderly Individuals Older than 90 Years , 1996, Journal of neuropathology and experimental neurology.

[72]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[73]  R. Terry.  Basis of Structural Alzheimer Disease and Some Pathogenic Concepts , 1997 .

[74]  J. Vickers.  A Cellular Mechanism for the Neuronal Changes Underlying Alzheimer‘s Disease , 1997, Neuroscience.

[75]  A. Smith,et al.  Relative roles of plaques and tangles in the dementia of Alzheimer's disease: correlations using three sets of neuropathological criteria. , 1995, Dementia.

[76]  R. Schiffer,et al.  Incorrect diagnosis of Alzheimer's disease. A clinicopathologic study. , 1996, Archives of neurology.

[77]  L Carlin,et al.  Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease. , 1995, Archives of neurology.

[78]  F. Huppert,et al.  Examination of the validity of the hierarchical model of neuropathological staging in normal aging and Alzheimer’s disease , 1998, Acta Neuropathologica.

[79]  H. Soininen,et al.  Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in alzheimer's disease , 1995, Neuroscience.

[80]  J. Price,et al.  Interlaboratory Histopathologic Assessment of Alzheimer Neuropathology: Different Methodologies Yield Comparable Diagnostic Results , 1993, Alzheimer disease and associated disorders.

[81]  B. Crain,et al.  Interlaboratory Comparison of Neuropathology Assessments in Alzheimer's Disease: A Study of the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1994, Journal of neuropathology and experimental neurology.

[82]  Patrick Vermersch,et al.  Cortical mapping of Alzheimer pathology in brains of aged non-demented subjects , 1995, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[83]  R. Mayer.  Alzheimer's disease--from molecular biology to therapy. , 1993, Trends in biotechnology.

[84]  L. H. Hughes,et al.  Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer’s disease? , 1997, Acta Neuropathologica.

[85]  K. Jellinger,et al.  Mechanisms of cell death in Alzheimer's disease. , 1997, Journal of neural transmission. Supplementum.

[86]  J. Trojanowski,et al.  Editorial on Consensus Recommendations for the Postmortem Diagnosis of Alzheimer Disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer Disease , 1997, Journal of neuropathology and experimental neurology.

[87]  M. Sliwinski,et al.  Pathological markers associated with normal aging and dementia in the elderly , 1993, Annals of neurology.

[88]  H. Chui,et al.  Neuropathologic Diagnosis of Alzheimer Disease: Interrater Reliability in the Assessment of Senile Plaques and Neurofibrillary Tangles , 1993, Alzheimer disease and associated disorders.

[89]  K. Gulya,et al.  The cholinergic system in Alzheimer's disease , 1997, Progress in Neurobiology.

[90]  E. Giacobini,et al.  Alzheimer disease, from molecular biology to therapy. , 1997, Advances in experimental medicine and biology.

[91]  P. Coleman,et al.  Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimer's disease , 1995, Neurobiology of Aging.

[92]  M. L. Schmidt,et al.  Autosomal dominant dementia with widespread neurofibrillary tangles , 1997, Annals of neurology.

[93]  S. DeKosky,et al.  Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severity , 1990, Annals of neurology.

[94]  L. Thal,et al.  Hippocampal Sclerosis Contributes to Dementia in the Elderly , 1997, Neurology.

[95]  W. Kamphorst,et al.  Distribution of beta amyloid associated proteins in plaques in Alzheimer's disease and in the non-demented elderly. , 1995, Neurodegeneration : a journal for neurodegenerative disorders, neuroprotection, and neuroregeneration.